March 28, 2026
Methodology About Contact
Subconscious Mind
The Vanderbilt Terminal for AI Consciousness & Neural Intelligence
CONSCIOUSNESS · NEURAL NETWORKS · BRAIN-COMPUTER INTERFACES · COGNITIVE COMPUTING
BCI Market Size: $2.94B ▲ +16.8% CAGR | Cognitive Computing: $48.88B ▲ +22.3% CAGR | Deep Learning Market: $34.28B ▲ +27.8% CAGR | Global AI Market: $390.9B ▲ +30.6% CAGR | Neuralink Implants: 3 Patients | AGI Median Forecast: 2040 | BCI Healthcare Share: 58.5% | Non-Invasive BCI: 81.9% | BCI Market Size: $2.94B ▲ +16.8% CAGR | Cognitive Computing: $48.88B ▲ +22.3% CAGR | Deep Learning Market: $34.28B ▲ +27.8% CAGR | Global AI Market: $390.9B ▲ +30.6% CAGR | Neuralink Implants: 3 Patients | AGI Median Forecast: 2040 | BCI Healthcare Share: 58.5% | Non-Invasive BCI: 81.9% |

Terms of Service

Terms of Service

Effective Date: March 25, 2026 Last Updated: March 25, 2026

These Terms of Service (“Terms”) govern your access to and use of subconsciousmind.ai (the “Site”), operated by Subconscious Mind, a publication of The Vanderbilt Portfolio AG (“we,” “us,” or “our”). By accessing or using the Site, you agree to be bound by these Terms. If you do not agree, you must not use the Site.

1. Acceptance of Terms

By accessing or using the Site, you represent and warrant that you are at least 16 years old and have the legal capacity to enter into these Terms. If you are accessing the Site on behalf of an organization, you represent that you have the authority to bind that organization to these Terms.

Your continued use of the Site following any changes to these Terms constitutes acceptance of those changes. We reserve the right to modify these Terms at any time, and such modifications will be effective immediately upon posting.

2. Description of Service

Subconscious Mind provides editorial content, market intelligence, data analysis, and research related to AI consciousness, neural networks, brain-computer interfaces, and cognitive computing. The Site publishes articles, dashboards, entity profiles, comparisons, glossary entries, and other informational content.

The Site is a journalism and research platform. Content published on the Site is for informational and educational purposes only.

3. Intellectual Property Rights

3.1 Our Content

All content on the Site, including but not limited to text, graphics, logos, icons, images, data compilations, and software, is the property of The Vanderbilt Portfolio AG or its licensors and is protected by international copyright, trademark, and other intellectual property laws.

3.2 Limited License

We grant you a limited, non-exclusive, non-transferable, revocable license to access and view the content on the Site for personal, non-commercial use. This license does not include:

  • Reproducing, distributing, or publicly displaying any content.
  • Modifying or creating derivative works from the content.
  • Using any data mining, scraping, or similar data-gathering tools.
  • Downloading or copying content for the benefit of a third party.
  • Using the content for commercial purposes without written permission.

3.3 Trademarks

Subconscious Mind, The Vanderbilt Portfolio, and related logos are trademarks of The Vanderbilt Portfolio AG. You may not use these marks without prior written consent.

4. User Conduct

When using the Site, you agree not to:

  • Use the Site for any unlawful purpose or in violation of any applicable law or regulation.
  • Attempt to gain unauthorized access to any portion of the Site, other accounts, or computer systems.
  • Interfere with or disrupt the Site, servers, or networks connected to the Site.
  • Use automated means (bots, scrapers, crawlers) to access the Site, except as explicitly permitted in our robots.txt file.
  • Reproduce, duplicate, copy, sell, resell, or exploit any portion of the Site for commercial purposes.
  • Transmit any viruses, malware, or other harmful code.
  • Impersonate any person or entity, or falsely state or misrepresent your affiliation with any person or entity.
  • Collect or store personal data about other users without their consent.

5. Disclaimer of Warranties

5.1 No Investment Advice

THE CONTENT ON THIS SITE IS FOR INFORMATIONAL PURPOSES ONLY AND DOES NOT CONSTITUTE INVESTMENT ADVICE, FINANCIAL ADVICE, TRADING ADVICE, OR ANY OTHER FORM OF PROFESSIONAL ADVICE. You should not rely on the content as a basis for making any financial, investment, or business decision. Always consult qualified professionals before making investment decisions.

5.2 No Warranty

THE SITE AND ITS CONTENT ARE PROVIDED ON AN “AS IS” AND “AS AVAILABLE” BASIS WITHOUT WARRANTIES OF ANY KIND, EITHER EXPRESS OR IMPLIED, INCLUDING BUT NOT LIMITED TO IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, NON-INFRINGEMENT, AND ACCURACY.

We do not warrant that:

  • The Site will be uninterrupted, timely, secure, or error-free.
  • The content will be accurate, reliable, complete, or current.
  • Any errors or defects will be corrected.
  • The Site is free of viruses or other harmful components.

5.3 Data Accuracy

While we strive to provide accurate and up-to-date information, data presented on the Site may contain errors, omissions, or inaccuracies. Market data, statistics, and financial figures are sourced from third-party providers and official publications but are not guaranteed to be accurate. All data is indicative and should be independently verified before use.

6. Limitation of Liability

TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW, IN NO EVENT SHALL THE VANDERBILT PORTFOLIO AG, ITS DIRECTORS, OFFICERS, EMPLOYEES, AGENTS, OR AFFILIATES BE LIABLE FOR ANY INDIRECT, INCIDENTAL, SPECIAL, CONSEQUENTIAL, OR PUNITIVE DAMAGES, INCLUDING BUT NOT LIMITED TO LOSS OF PROFITS, DATA, USE, GOODWILL, OR OTHER INTANGIBLE LOSSES, ARISING OUT OF OR RELATING TO:

  • Your access to or use of (or inability to access or use) the Site.
  • Any conduct or content of any third party on the Site.
  • Any content obtained from the Site.
  • Unauthorized access, use, or alteration of your transmissions or content.

OUR TOTAL LIABILITY FOR ALL CLAIMS ARISING FROM YOUR USE OF THE SITE SHALL NOT EXCEED ONE HUNDRED US DOLLARS (USD $100).

The Site contains links to third-party websites and resources, including sister sites within The Vanderbilt Portfolio network and external authority sources. We provide these links for your convenience but do not endorse, control, or assume responsibility for the content, privacy policies, or practices of any third-party websites.

You access third-party websites at your own risk and subject to their respective terms and conditions.

8. Advertising

The Site displays advertisements served by Google AdSense and potentially other advertising networks. We are not responsible for the content of advertisements or for any products or services advertised. The presence of an advertisement on the Site does not constitute an endorsement.

Advertising is subject to our Cookie Policy and Privacy Policy. You can control advertising cookie preferences through our cookie consent banner.

9. Premium Content

Certain content on the Site may be designated as premium and may require a subscription or payment to access. Specific terms governing premium subscriptions will be presented at the time of purchase and supplement these Terms.

10. Indemnification

You agree to indemnify, defend, and hold harmless The Vanderbilt Portfolio AG, its officers, directors, employees, agents, and affiliates from and against any claims, liabilities, damages, losses, costs, and expenses (including reasonable attorneys’ fees) arising out of or relating to:

  • Your use of the Site.
  • Your violation of these Terms.
  • Your violation of any applicable law or the rights of any third party.
  • Any content you submit or transmit through the Site.

11. Termination

We reserve the right to terminate or suspend your access to the Site at any time, without notice, for any reason, including violation of these Terms. Upon termination, your right to use the Site ceases immediately. All provisions of these Terms that by their nature should survive termination shall survive.

12. Governing Law and Dispute Resolution

These Terms shall be governed by and construed in accordance with the laws of Switzerland, without regard to conflict of law principles. Any dispute arising from or relating to these Terms or the Site shall be resolved through binding arbitration in accordance with the rules of the Swiss Chambers’ Arbitration Institution, conducted in English.

13. Severability

If any provision of these Terms is found to be invalid, illegal, or unenforceable, the remaining provisions shall continue in full force and effect. The invalid provision shall be modified to the minimum extent necessary to make it valid and enforceable.

14. Entire Agreement

These Terms, together with our Privacy Policy and Cookie Policy, constitute the entire agreement between you and The Vanderbilt Portfolio AG regarding your use of the Site. These Terms supersede all prior agreements and understandings.

15. Waiver

Our failure to enforce any right or provision of these Terms shall not constitute a waiver of such right or provision. A waiver of any term shall not be deemed a waiver of any other term.

16. Assignment

You may not assign or transfer these Terms or your rights hereunder without our prior written consent. We may assign our rights and obligations under these Terms without restriction.

17. Force Majeure

We shall not be liable for any failure or delay in performing our obligations where such failure or delay results from circumstances beyond our reasonable control, including but not limited to acts of God, natural disasters, pandemic, war, terrorism, labor disputes, government actions, power failures, or internet disruptions.

18. Contact Information

For questions about these Terms, contact us at:

Subconscious Mind Operated by The Vanderbilt Portfolio AG Email: info@subconsciousmind.ai Website: https://subconsciousmind.ai/

19. Specific Terms for Intelligence Content

The intelligence content published on Subconscious Mind — including analysis of AI consciousness, neural network architectures, brain-computer interface technology, and cognitive computing markets — is subject to the following additional terms:

Research Data: Market data, financial figures, and statistical claims presented on the Site are sourced from third-party research firms (Precedence Research, Grand View Research, Straits Research, IDTechEx) and official publications. All data is indicative and subject to the methodological limitations of the source. See our Methodology page for details on data sourcing and verification.

Entity Profiles: Our entity profiles of companies including Neuralink, Synchron, Anthropic, OpenAI, and Google DeepMind are based on publicly available information and do not constitute endorsement, recommendation, or investment advice. Profiles are updated periodically and may not reflect the most current information.

Consciousness Assessment: Our coverage of consciousness indicators and consciousness assessment methodology is informational and educational. Nothing on this Site constitutes a definitive determination about the consciousness status of any AI system. The consciousness indicators framework provides probabilistic assessment tools, not definitive conclusions.

Market Forecasts: Forward-looking market projections (including the $390.9 billion AI market, $2.94 billion BCI market, $48.88 billion cognitive computing market, and $34.28 billion deep learning market projections) are based on third-party analyst estimates and are inherently uncertain. Actual market outcomes may differ materially from projections.

Regulatory Coverage: Our coverage of FDA regulatory pathways for BCI devices, AGI governance frameworks, and emerging AI regulation is informational only and does not constitute legal or regulatory advice. Companies navigating regulatory requirements should consult qualified regulatory counsel. Our regulatory analysis reflects our interpretation of publicly available regulatory guidance and does not represent FDA, EU, UK MHRA, or any other regulatory authority’s official position.

Data Retention and Research Methodology: Our market data, clinical trial tracking, and technology assessments are compiled from publicly available sources including peer-reviewed scientific publications, regulatory filings with the FDA and international health authorities, corporate disclosures, and reports from established market research firms. We maintain editorial independence from the companies and organizations we cover, including Neuralink, Synchron, Anthropic, OpenAI, and all other entities profiled on the Site. Our research methodology is described in our Methodology page. Data is refreshed quarterly for market dashboards and as events warrant for intelligence briefs and entity profiles. Historical data and archived analyses may not reflect current conditions and should not be relied upon for time-sensitive decisions. Users are encouraged to verify all data independently before making any decisions based on content published on the Site. Our editorial team reserves the right to update, correct, or retract content at any time as new information becomes available, and we welcome corrections submitted through our contact channels.

Scientific Claims: Our coverage of consciousness theories, neural network architectures, and neurotechnology presents scientific information as accurately as possible, but science is inherently provisional and subject to revision as new evidence emerges. We clearly distinguish between established scientific consensus, active areas of research debate, and speculative projections. Readers should not rely on our scientific coverage as a substitute for consulting primary research literature or qualified scientific experts.

Automated Content and AI Assistance: Certain analytical outputs on the Site, including market data visualizations, entity profile summaries, and comparison matrices, may be generated or augmented with the assistance of artificial intelligence tools. All AI-generated or AI-assisted content undergoes editorial review by our research team before publication to ensure accuracy, completeness, and editorial quality. The use of AI tools in our editorial workflow does not diminish the standards of accuracy and intellectual rigor applied to published content.

For privacy-related inquiries, please see our Privacy Policy. For information about our data sources and editorial process, see our Methodology page.

Institutional Access

Coming Soon